Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 14:57:10 UTC
Update Date2021-09-26 23:10:02 UTC
HMDB IDHMDB0255325
Secondary Accession NumbersNone
Metabolite Identification
Common Name(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid
Description(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid belongs to the class of organic compounds known as alpha amino acids. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). Based on a literature review very few articles have been published on (2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid. This compound has been identified in human blood as reported by (PMID: 31557052 ). (2s)-2-amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically (2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoateGenerator
Chemical FormulaC12H23N3O3
Average Molecular Weight257.334
Monoisotopic Molecular Weight257.173941613
IUPAC Name2-amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid
Traditional Name2-amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid
CAS Registry NumberNot Available
SMILES
NC(CCCCNN1CCCC(C1)C=O)C(O)=O
InChI Identifier
InChI=1S/C12H23N3O3/c13-11(12(17)18)5-1-2-6-14-15-7-3-4-10(8-15)9-16/h9-11,14H,1-8,13H2,(H,17,18)
InChI KeyKVXSPXCUAWCXEI-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as alpha amino acids. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon).
KingdomOrganic compounds
Super ClassOrganic acids and derivatives
ClassCarboxylic acids and derivatives
Sub ClassAmino acids, peptides, and analogues
Direct ParentAlpha amino acids
Alternative Parents
Substituents
  • Alpha-amino acid
  • Medium-chain fatty acid
  • Heterocyclic fatty acid
  • Amino fatty acid
  • Fatty acyl
  • Fatty acid
  • Piperidine
  • Amino acid
  • Alkylhydrazine
  • Azacycle
  • Organoheterocyclic compound
  • Monocarboxylic acid or derivatives
  • Carboxylic acid
  • Organic nitrogen compound
  • Organic oxygen compound
  • Organopnictogen compound
  • Organic oxide
  • Hydrocarbon derivative
  • Primary amine
  • Organooxygen compound
  • Organonitrogen compound
  • Primary aliphatic amine
  • Hydrazine derivative
  • Carbonyl group
  • Amine
  • Aldehyde
  • Aliphatic heteromonocyclic compound
Molecular FrameworkAliphatic heteromonocyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP-1.6ALOGPS
logP-2.9ChemAxon
logS-1.4ALOGPS
pKa (Strongest Acidic)2.44ChemAxon
pKa (Strongest Basic)9.53ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count6ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area95.66 ŲChemAxon
Rotatable Bond Count8ChemAxon
Refractivity78.7 m³·mol⁻¹ChemAxon
Polarizability28.89 ųChemAxon
Number of Rings1ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+153.3330932474
DeepCCS[M-H]-149.50330932474
DeepCCS[M-2H]-186.82430932474
DeepCCS[M+Na]+162.48730932474

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acidNC(CCCCNN1CCCC(C1)C=O)C(O)=O3004.9Standard polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acidNC(CCCCNN1CCCC(C1)C=O)C(O)=O2227.1Standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acidNC(CCCCNN1CCCC(C1)C=O)C(O)=O2295.9Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,2TMS,isomer #1C[Si](C)(C)OC=C1CCCN(NCCCCC(N)C(=O)O[Si](C)(C)C)C12419.7Semi standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,2TMS,isomer #1C[Si](C)(C)OC=C1CCCN(NCCCCC(N)C(=O)O[Si](C)(C)C)C12255.0Standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,2TMS,isomer #1C[Si](C)(C)OC=C1CCCN(NCCCCC(N)C(=O)O[Si](C)(C)C)C13590.8Standard polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,2TMS,isomer #2C[Si](C)(C)NC(CCCCNN1CCCC(C=O)C1)C(=O)O[Si](C)(C)C2412.2Semi standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,2TMS,isomer #2C[Si](C)(C)NC(CCCCNN1CCCC(C=O)C1)C(=O)O[Si](C)(C)C2419.3Standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,2TMS,isomer #2C[Si](C)(C)NC(CCCCNN1CCCC(C=O)C1)C(=O)O[Si](C)(C)C3187.8Standard polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,2TMS,isomer #3C[Si](C)(C)OC(=O)C(N)CCCCN(N1CCCC(C=O)C1)[Si](C)(C)C2331.2Semi standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,2TMS,isomer #3C[Si](C)(C)OC(=O)C(N)CCCCN(N1CCCC(C=O)C1)[Si](C)(C)C2393.3Standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,2TMS,isomer #3C[Si](C)(C)OC(=O)C(N)CCCCN(N1CCCC(C=O)C1)[Si](C)(C)C3538.1Standard polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,2TMS,isomer #4C[Si](C)(C)NC(CCCCNN1CCCC(=CO[Si](C)(C)C)C1)C(=O)O2532.6Semi standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,2TMS,isomer #4C[Si](C)(C)NC(CCCCNN1CCCC(=CO[Si](C)(C)C)C1)C(=O)O2275.8Standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,2TMS,isomer #4C[Si](C)(C)NC(CCCCNN1CCCC(=CO[Si](C)(C)C)C1)C(=O)O3469.7Standard polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,2TMS,isomer #5C[Si](C)(C)OC=C1CCCN(N(CCCCC(N)C(=O)O)[Si](C)(C)C)C12446.2Semi standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,2TMS,isomer #5C[Si](C)(C)OC=C1CCCN(N(CCCCC(N)C(=O)O)[Si](C)(C)C)C12331.5Standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,2TMS,isomer #5C[Si](C)(C)OC=C1CCCN(N(CCCCC(N)C(=O)O)[Si](C)(C)C)C13763.3Standard polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,2TMS,isomer #6C[Si](C)(C)N(C(CCCCNN1CCCC(C=O)C1)C(=O)O)[Si](C)(C)C2582.5Semi standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,2TMS,isomer #6C[Si](C)(C)N(C(CCCCNN1CCCC(C=O)C1)C(=O)O)[Si](C)(C)C2488.2Standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,2TMS,isomer #6C[Si](C)(C)N(C(CCCCNN1CCCC(C=O)C1)C(=O)O)[Si](C)(C)C3370.8Standard polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,2TMS,isomer #7C[Si](C)(C)NC(CCCCN(N1CCCC(C=O)C1)[Si](C)(C)C)C(=O)O2466.2Semi standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,2TMS,isomer #7C[Si](C)(C)NC(CCCCN(N1CCCC(C=O)C1)[Si](C)(C)C)C(=O)O2391.8Standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,2TMS,isomer #7C[Si](C)(C)NC(CCCCN(N1CCCC(C=O)C1)[Si](C)(C)C)C(=O)O3364.3Standard polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,3TMS,isomer #1C[Si](C)(C)NC(CCCCNN1CCCC(=CO[Si](C)(C)C)C1)C(=O)O[Si](C)(C)C2511.0Semi standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,3TMS,isomer #1C[Si](C)(C)NC(CCCCNN1CCCC(=CO[Si](C)(C)C)C1)C(=O)O[Si](C)(C)C2291.6Standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,3TMS,isomer #1C[Si](C)(C)NC(CCCCNN1CCCC(=CO[Si](C)(C)C)C1)C(=O)O[Si](C)(C)C3087.5Standard polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,3TMS,isomer #2C[Si](C)(C)OC=C1CCCN(N(CCCCC(N)C(=O)O[Si](C)(C)C)[Si](C)(C)C)C12431.0Semi standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,3TMS,isomer #2C[Si](C)(C)OC=C1CCCN(N(CCCCC(N)C(=O)O[Si](C)(C)C)[Si](C)(C)C)C12390.6Standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,3TMS,isomer #2C[Si](C)(C)OC=C1CCCN(N(CCCCC(N)C(=O)O[Si](C)(C)C)[Si](C)(C)C)C13406.1Standard polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,3TMS,isomer #3C[Si](C)(C)OC(=O)C(CCCCNN1CCCC(C=O)C1)N([Si](C)(C)C)[Si](C)(C)C2570.2Semi standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,3TMS,isomer #3C[Si](C)(C)OC(=O)C(CCCCNN1CCCC(C=O)C1)N([Si](C)(C)C)[Si](C)(C)C2573.0Standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,3TMS,isomer #3C[Si](C)(C)OC(=O)C(CCCCNN1CCCC(C=O)C1)N([Si](C)(C)C)[Si](C)(C)C2991.8Standard polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,3TMS,isomer #4C[Si](C)(C)NC(CCCCN(N1CCCC(C=O)C1)[Si](C)(C)C)C(=O)O[Si](C)(C)C2422.6Semi standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,3TMS,isomer #4C[Si](C)(C)NC(CCCCN(N1CCCC(C=O)C1)[Si](C)(C)C)C(=O)O[Si](C)(C)C2461.9Standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,3TMS,isomer #4C[Si](C)(C)NC(CCCCN(N1CCCC(C=O)C1)[Si](C)(C)C)C(=O)O[Si](C)(C)C2965.0Standard polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,3TMS,isomer #5C[Si](C)(C)OC=C1CCCN(NCCCCC(C(=O)O)N([Si](C)(C)C)[Si](C)(C)C)C12669.2Semi standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,3TMS,isomer #5C[Si](C)(C)OC=C1CCCN(NCCCCC(C(=O)O)N([Si](C)(C)C)[Si](C)(C)C)C12407.2Standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,3TMS,isomer #5C[Si](C)(C)OC=C1CCCN(NCCCCC(C(=O)O)N([Si](C)(C)C)[Si](C)(C)C)C13251.5Standard polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,3TMS,isomer #6C[Si](C)(C)NC(CCCCN(N1CCCC(=CO[Si](C)(C)C)C1)[Si](C)(C)C)C(=O)O2512.2Semi standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,3TMS,isomer #6C[Si](C)(C)NC(CCCCN(N1CCCC(=CO[Si](C)(C)C)C1)[Si](C)(C)C)C(=O)O2429.6Standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,3TMS,isomer #6C[Si](C)(C)NC(CCCCN(N1CCCC(=CO[Si](C)(C)C)C1)[Si](C)(C)C)C(=O)O3248.5Standard polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,3TMS,isomer #7C[Si](C)(C)N(CCCCC(C(=O)O)N([Si](C)(C)C)[Si](C)(C)C)N1CCCC(C=O)C12608.8Semi standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,3TMS,isomer #7C[Si](C)(C)N(CCCCC(C(=O)O)N([Si](C)(C)C)[Si](C)(C)C)N1CCCC(C=O)C12522.1Standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,3TMS,isomer #7C[Si](C)(C)N(CCCCC(C(=O)O)N([Si](C)(C)C)[Si](C)(C)C)N1CCCC(C=O)C13142.1Standard polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,4TMS,isomer #1C[Si](C)(C)OC=C1CCCN(NCCCCC(C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C)C12641.1Semi standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,4TMS,isomer #1C[Si](C)(C)OC=C1CCCN(NCCCCC(C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C)C12409.8Standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,4TMS,isomer #1C[Si](C)(C)OC=C1CCCN(NCCCCC(C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C)C12948.7Standard polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,4TMS,isomer #2C[Si](C)(C)NC(CCCCN(N1CCCC(=CO[Si](C)(C)C)C1)[Si](C)(C)C)C(=O)O[Si](C)(C)C2503.8Semi standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,4TMS,isomer #2C[Si](C)(C)NC(CCCCN(N1CCCC(=CO[Si](C)(C)C)C1)[Si](C)(C)C)C(=O)O[Si](C)(C)C2456.4Standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,4TMS,isomer #2C[Si](C)(C)NC(CCCCN(N1CCCC(=CO[Si](C)(C)C)C1)[Si](C)(C)C)C(=O)O[Si](C)(C)C2925.7Standard polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,4TMS,isomer #3C[Si](C)(C)OC(=O)C(CCCCN(N1CCCC(C=O)C1)[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C2613.1Semi standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,4TMS,isomer #3C[Si](C)(C)OC(=O)C(CCCCN(N1CCCC(C=O)C1)[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C2564.6Standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,4TMS,isomer #3C[Si](C)(C)OC(=O)C(CCCCN(N1CCCC(C=O)C1)[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C2816.3Standard polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,4TMS,isomer #4C[Si](C)(C)OC=C1CCCN(N(CCCCC(C(=O)O)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)C12668.1Semi standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,4TMS,isomer #4C[Si](C)(C)OC=C1CCCN(N(CCCCC(C(=O)O)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)C12542.8Standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,4TMS,isomer #4C[Si](C)(C)OC=C1CCCN(N(CCCCC(C(=O)O)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)C13092.6Standard polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,5TMS,isomer #1C[Si](C)(C)OC=C1CCCN(N(CCCCC(C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)C12715.9Semi standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,5TMS,isomer #1C[Si](C)(C)OC=C1CCCN(N(CCCCC(C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)C12546.1Standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,5TMS,isomer #1C[Si](C)(C)OC=C1CCCN(N(CCCCC(C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)C12824.6Standard polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC=C1CCCN(NCCCCC(N)C(=O)O[Si](C)(C)C(C)(C)C)C12884.2Semi standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC=C1CCCN(NCCCCC(N)C(=O)O[Si](C)(C)C(C)(C)C)C12607.0Standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC=C1CCCN(NCCCCC(N)C(=O)O[Si](C)(C)C(C)(C)C)C13617.9Standard polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,2TBDMS,isomer #2CC(C)(C)[Si](C)(C)NC(CCCCNN1CCCC(C=O)C1)C(=O)O[Si](C)(C)C(C)(C)C2843.0Semi standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,2TBDMS,isomer #2CC(C)(C)[Si](C)(C)NC(CCCCNN1CCCC(C=O)C1)C(=O)O[Si](C)(C)C(C)(C)C2889.9Standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,2TBDMS,isomer #2CC(C)(C)[Si](C)(C)NC(CCCCNN1CCCC(C=O)C1)C(=O)O[Si](C)(C)C(C)(C)C3205.3Standard polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,2TBDMS,isomer #3CC(C)(C)[Si](C)(C)OC(=O)C(N)CCCCN(N1CCCC(C=O)C1)[Si](C)(C)C(C)(C)C2793.5Semi standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,2TBDMS,isomer #3CC(C)(C)[Si](C)(C)OC(=O)C(N)CCCCN(N1CCCC(C=O)C1)[Si](C)(C)C(C)(C)C2813.9Standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,2TBDMS,isomer #3CC(C)(C)[Si](C)(C)OC(=O)C(N)CCCCN(N1CCCC(C=O)C1)[Si](C)(C)C(C)(C)C3507.0Standard polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,2TBDMS,isomer #4CC(C)(C)[Si](C)(C)NC(CCCCNN1CCCC(=CO[Si](C)(C)C(C)(C)C)C1)C(=O)O2965.6Semi standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,2TBDMS,isomer #4CC(C)(C)[Si](C)(C)NC(CCCCNN1CCCC(=CO[Si](C)(C)C(C)(C)C)C1)C(=O)O2626.4Standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,2TBDMS,isomer #4CC(C)(C)[Si](C)(C)NC(CCCCNN1CCCC(=CO[Si](C)(C)C(C)(C)C)C1)C(=O)O3497.7Standard polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,2TBDMS,isomer #5CC(C)(C)[Si](C)(C)OC=C1CCCN(N(CCCCC(N)C(=O)O)[Si](C)(C)C(C)(C)C)C12885.2Semi standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,2TBDMS,isomer #5CC(C)(C)[Si](C)(C)OC=C1CCCN(N(CCCCC(N)C(=O)O)[Si](C)(C)C(C)(C)C)C12698.8Standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,2TBDMS,isomer #5CC(C)(C)[Si](C)(C)OC=C1CCCN(N(CCCCC(N)C(=O)O)[Si](C)(C)C(C)(C)C)C13760.1Standard polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,2TBDMS,isomer #6CC(C)(C)[Si](C)(C)N(C(CCCCNN1CCCC(C=O)C1)C(=O)O)[Si](C)(C)C(C)(C)C3017.4Semi standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,2TBDMS,isomer #6CC(C)(C)[Si](C)(C)N(C(CCCCNN1CCCC(C=O)C1)C(=O)O)[Si](C)(C)C(C)(C)C2926.7Standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,2TBDMS,isomer #6CC(C)(C)[Si](C)(C)N(C(CCCCNN1CCCC(C=O)C1)C(=O)O)[Si](C)(C)C(C)(C)C3356.0Standard polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,2TBDMS,isomer #7CC(C)(C)[Si](C)(C)NC(CCCCN(N1CCCC(C=O)C1)[Si](C)(C)C(C)(C)C)C(=O)O2907.5Semi standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,2TBDMS,isomer #7CC(C)(C)[Si](C)(C)NC(CCCCN(N1CCCC(C=O)C1)[Si](C)(C)C(C)(C)C)C(=O)O2813.1Standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,2TBDMS,isomer #7CC(C)(C)[Si](C)(C)NC(CCCCN(N1CCCC(C=O)C1)[Si](C)(C)C(C)(C)C)C(=O)O3366.0Standard polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)NC(CCCCNN1CCCC(=CO[Si](C)(C)C(C)(C)C)C1)C(=O)O[Si](C)(C)C(C)(C)C3127.6Semi standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)NC(CCCCNN1CCCC(=CO[Si](C)(C)C(C)(C)C)C1)C(=O)O[Si](C)(C)C(C)(C)C2832.9Standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)NC(CCCCNN1CCCC(=CO[Si](C)(C)C(C)(C)C)C1)C(=O)O[Si](C)(C)C(C)(C)C3232.9Standard polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,3TBDMS,isomer #2CC(C)(C)[Si](C)(C)OC=C1CCCN(N(CCCCC(N)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C13104.3Semi standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,3TBDMS,isomer #2CC(C)(C)[Si](C)(C)OC=C1CCCN(N(CCCCC(N)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C12902.6Standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,3TBDMS,isomer #2CC(C)(C)[Si](C)(C)OC=C1CCCN(N(CCCCC(N)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C13492.4Standard polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,3TBDMS,isomer #3CC(C)(C)[Si](C)(C)OC(=O)C(CCCCNN1CCCC(C=O)C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3236.1Semi standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,3TBDMS,isomer #3CC(C)(C)[Si](C)(C)OC(=O)C(CCCCNN1CCCC(C=O)C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3198.6Standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,3TBDMS,isomer #3CC(C)(C)[Si](C)(C)OC(=O)C(CCCCNN1CCCC(C=O)C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3134.3Standard polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,3TBDMS,isomer #4CC(C)(C)[Si](C)(C)NC(CCCCN(N1CCCC(C=O)C1)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C3080.0Semi standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,3TBDMS,isomer #4CC(C)(C)[Si](C)(C)NC(CCCCN(N1CCCC(C=O)C1)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C3026.4Standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,3TBDMS,isomer #4CC(C)(C)[Si](C)(C)NC(CCCCN(N1CCCC(C=O)C1)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C3148.3Standard polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,3TBDMS,isomer #5CC(C)(C)[Si](C)(C)OC=C1CCCN(NCCCCC(C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C13288.8Semi standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,3TBDMS,isomer #5CC(C)(C)[Si](C)(C)OC=C1CCCN(NCCCCC(C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C12923.9Standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,3TBDMS,isomer #5CC(C)(C)[Si](C)(C)OC=C1CCCN(NCCCCC(C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C13345.1Standard polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,3TBDMS,isomer #6CC(C)(C)[Si](C)(C)NC(CCCCN(N1CCCC(=CO[Si](C)(C)C(C)(C)C)C1)[Si](C)(C)C(C)(C)C)C(=O)O3181.4Semi standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,3TBDMS,isomer #6CC(C)(C)[Si](C)(C)NC(CCCCN(N1CCCC(=CO[Si](C)(C)C(C)(C)C)C1)[Si](C)(C)C(C)(C)C)C(=O)O2933.8Standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,3TBDMS,isomer #6CC(C)(C)[Si](C)(C)NC(CCCCN(N1CCCC(=CO[Si](C)(C)C(C)(C)C)C1)[Si](C)(C)C(C)(C)C)C(=O)O3373.6Standard polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,3TBDMS,isomer #7CC(C)(C)[Si](C)(C)N(CCCCC(C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N1CCCC(C=O)C13255.9Semi standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,3TBDMS,isomer #7CC(C)(C)[Si](C)(C)N(CCCCC(C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N1CCCC(C=O)C13060.5Standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,3TBDMS,isomer #7CC(C)(C)[Si](C)(C)N(CCCCC(C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N1CCCC(C=O)C13259.9Standard polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,4TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC=C1CCCN(NCCCCC(C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C13488.3Semi standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,4TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC=C1CCCN(NCCCCC(C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C13093.3Standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,4TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC=C1CCCN(NCCCCC(C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C13172.1Standard polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,4TBDMS,isomer #2CC(C)(C)[Si](C)(C)NC(CCCCN(N1CCCC(=CO[Si](C)(C)C(C)(C)C)C1)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C3379.7Semi standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,4TBDMS,isomer #2CC(C)(C)[Si](C)(C)NC(CCCCN(N1CCCC(=CO[Si](C)(C)C(C)(C)C)C1)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C3085.9Standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,4TBDMS,isomer #2CC(C)(C)[Si](C)(C)NC(CCCCN(N1CCCC(=CO[Si](C)(C)C(C)(C)C)C1)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C3196.6Standard polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,4TBDMS,isomer #3CC(C)(C)[Si](C)(C)OC(=O)C(CCCCN(N1CCCC(C=O)C1)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3488.7Semi standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,4TBDMS,isomer #3CC(C)(C)[Si](C)(C)OC(=O)C(CCCCN(N1CCCC(C=O)C1)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3262.8Standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,4TBDMS,isomer #3CC(C)(C)[Si](C)(C)OC(=O)C(CCCCN(N1CCCC(C=O)C1)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3067.6Standard polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,4TBDMS,isomer #4CC(C)(C)[Si](C)(C)OC=C1CCCN(N(CCCCC(C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C13523.0Semi standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,4TBDMS,isomer #4CC(C)(C)[Si](C)(C)OC=C1CCCN(N(CCCCC(C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C13156.9Standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,4TBDMS,isomer #4CC(C)(C)[Si](C)(C)OC=C1CCCN(N(CCCCC(C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C13282.9Standard polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,5TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC=C1CCCN(N(CCCCC(C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C13767.7Semi standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,5TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC=C1CCCN(N(CCCCC(C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C13294.7Standard non polar33892256
(2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid,5TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC=C1CCCN(N(CCCCC(C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C13158.4Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - (2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid GC-MS (Non-derivatized) - 70eV, Positivesplash10-03dl-9820000000-4b31e8cec56e4d13cfe82021-09-23Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - (2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - (2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid GC-MS (TMS_1_1) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - (2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid GC-MS (TMS_1_2) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - (2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid GC-MS (TMS_1_3) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - (2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid GC-MS (TMS_1_4) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - (2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid GC-MS (TBDMS_1_1) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - (2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid GC-MS (TBDMS_1_2) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - (2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid GC-MS (TBDMS_1_3) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - (2S)-2-Amino-6-[(3-formylpiperidin-1-yl)amino]hexanoic acid GC-MS (TBDMS_1_4) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum

NMR Spectra

Spectrum TypeDescriptionDeposition DateSourceView
Predicted 1D NMR13C NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-10-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-10-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-10-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-10-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-10-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-10-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-10-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-10-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-10-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-10-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-10-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-10-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-10-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-10-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-10-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-10-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-10-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-10-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-10-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-10-25Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider IDNot Available
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem CompoundNot Available
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]